Showing all 10 results
Cefixime and Ofloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Extracellular Specialist: Targets the bacterial cell wall; highly effective against Gram-negative enteric pathogens. Ofloxacin USP/Ph.Eur. 200 mg The Intracellular Specialist: Targets DNA replication; excellent tissue penetration into the lungs, prostate, and urinary tract. Excipients Proprietary Matrix Bilayer Technology: Engineered to prevent physical interaction between the two APIs, ensuring maximum stability and a synchronized release profile in the gut. Clofazimine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micronized Lipid-Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive phenazine dye.
Active Ingredient Strength Primary Clinical Function Clofazimine USP/Ph.Eur. 50 mg The Standard MDT Maintenance Unit: The globally standardized daily dose utilized in the WHO Multi-Drug Therapy (MDT) regimen for Multibacillary Leprosy. Clofazimine USP/Ph.Eur. 100 mg The MDR-TB & Acute ENL Macrodose: The heavy therapeutic payload utilized for the aggressive suppression of acute ENL reactions or as a core component of the standardized short-course MDR-TB regimen. Excipients Microcrystalline Cellulose / Propylene Glycol / Gelatin / Sodium Lauryl Sulfate / Magnesium Stearate / Heavy Opaque Polymeric Film Diluent / Lipid-Solvent Matrix / Binder / Surfactant / Lubricant / Protective Light Shield (Engineered specifically utilizing Advanced API Micronization & Solid-Lipid Tableting. Because Clofazimine is practically insoluble in water, the API is micro-milled and suspended in a specialized surfactant matrix to ensure it absorbs perfectly in the gut without requiring a soft-gelatin encapsulation process) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, continuous, multi-year infectious disease dispensing regimens).
Diloxanide furoate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Luminal-Dispersion Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the anti-parasitic ester.
Active Ingredient Strength Primary Clinical Function Diloxanide Furoate USP/Ph.Eur. 500 mg The Global Anti-Parasitic Standard: The definitive therapeutic macrodose utilized globally for the total luminal eradication of amoebic cysts in asymptomatic carriers and post-dysentery patients. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced high-shear granulation and elite superdisintegrants to ensure the massive 500mg tablet shatters and disperses uniformly across the intestinal lining, maximizing physical contact with the embedded cysts) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, 10-day acute parasitology eradication regimens).
